Literature DB >> 6224502

A radionuclide method for the simultaneous study of the effects of drugs on central and peripheral haemodynamics.

C G Wathen, W J Hannan, C J Adie, A L Muir.   

Abstract

Mesh：

Substances：

Year:  1983        PMID： 6224502      PMCID： PMC1427954          DOI： 10.1111/j.1365-2125.1983.tb02142.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  A study of the mechanism of the hemodynamic effects of hydralazine in man.

Authors:  B ABLAD
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1963

2.  The measurement of volume changes in human limbs.

Authors:  R J WHITNEY
Journal:  J Physiol       Date:  1953-07       Impact factor: 5.182

Review 3.  Medical intelligence drug therapy.

Authors:  J Koch-Weser
Journal:  N Engl J Med       Date:  1976-08-05       Impact factor: 91.245

4.  A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.

Authors:  R J Callahan; J W Froelich; K A McKusick; J Leppo; H W Strauss
Journal:  J Nucl Med       Date:  1982-04       Impact factor: 10.057

5.  Relationship between the direct inhibitory effect of hydralazine and propildazine on arterial smooth muscle contractility and sympathetic innervation.

Authors:  M Worcel
Journal:  J Pharmacol Exp Ther       Date:  1978-11       Impact factor: 4.030

6.  The effects of isoprenaline, atropine and dobutamine on ventricular volume curves obtained by radionuclide ventriculography.

Authors:  A L Muir; W J Hannan; R P Sapru; A K Boardman; P K Wraith; H M Brash
Journal:  Clin Sci (Lond)       Date:  1980-05       Impact factor: 6.124

7.  An evaluation of six kits of technetium 99m human serum albumin injection for cardiac blood pool imaging.

Authors:  A M Millar; W J Hannan; R P Sapru; A L Muir
Journal:  Eur J Nucl Med       Date:  1979-04-01

8.  Inhibition by hydralazine of the conversion of dopamine to noradrenaline in rat atria in vitro and in vivo.

Authors:  P Songkittiguna; H Majewski; M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1980 Sep-Oct       Impact factor: 2.557

9.  Hemodynamic advantage of combined administration of hydralazine orally and nitrates nonparenterally in the vasodilator therapy of chronic heart failure.

Authors:  B Massie; K Chatterjee; J Werner; B Greenberg; R Hart; W W Parmley
Journal:  Am J Cardiol       Date:  1977-11       Impact factor: 2.778

10.  Radionuclide assessment of peripheral intravascular capacity: a technique to measure intravascular volume changes in the capacitance circulation in man.

Authors:  D L Rutlen; F J Wackers; B L Zaret
Journal:  Circulation       Date:  1981-07       Impact factor: 29.690
View more
  7 in total

Review 1.  Assessment of venous capacitance. Radionuclide plethysmography: methodology and research applications.

Authors:  Matthias Schmitt; Daniel J Blackman; Gordon W Middleton; John R Cockcroft; Michael P Frenneaux
Journal:  Br J Clin Pharmacol       Date:  2002-12       Impact factor: 4.335

2.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

3.  The haemodynamic effects of long term felodipine therapy in previously untreated essential hypertension.

Authors:  S Capewell; C G Wathen; W J Hannan; A L Muir
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Acute and chronic arterial and venous effects of captopril in congestive cardiac failure.

Authors:  S Capewell; D Taverner; W J Hannan; A L Muir
Journal:  BMJ       Date:  1989-10-14

5.  Lack of variation in venous tone potentiates vasovagal syncope.

Authors:  A D Hargreaves; A L Muir
Journal:  Br Heart J       Date:  1992-06

6.  Effects of felodipine on resistance and capacitance vessels in patients with essential hypertension.

Authors:  A L Muir; C G Wathen; W J Hannan
Journal:  Drugs       Date:  1985       Impact factor: 9.546

7.  Central and peripheral haemodynamic responses to felodipine in congestive heart failure.

Authors:  S Capewell; C G Wathen; A L Muir
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.